ask="60.00"
ask_size="100"
average_daily_volume="391375"
bid="29.76"
bid_size="100"
book_value="14.23"
change="-1.10"
change_from_200_day_moving_average="-9.89"
change_from_50_day_moving_average="-5.21"
change_from_52_week_high="-21.22"
change_From_52_week_low="8.57"
change_in_percent="-2.69%"
close="39.76"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="9.05"
ebitda="-97.47M"
eps_estimate_current_year="-4.38"
eps_estimate_next_quarter="-1.15"
eps_estimate_next_year="-3.84"
ex_dividend_date="N/A"
float_shares="24639000"
high="41.15"
high_52_weeks="60.98"
last_trade_date="3/14/2017"
last_trade_price="39.76"
last_trade_size="25038"
last_trade_time="4:00pm"
low="39.42"
low_52_weeks="31.19"
market_capitalization="1.09B"
moving_average_200_day="49.65"
moving_average_50_day="44.97"
name="Five Prime Therapeutics
Inc."
notes="N/A"
one_year_target_price="65.29"
open="40.57"
pe_ratio="N/A"
peg_ratio="0.16"
percent_change_from_200_day_moving_average="-19.92%"
percent_change_from_50_day_moving_average="-11.58%"
percent_change_from_52_week_high="-34.80%"
percent_change_from_52_week_low="+27.48%"
previous_close="40.86"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="2.87"
price_per_sales="36.62"
revenue="30.69M"
shares_outstanding="27509000"
short_ratio="8.04"
stock_exchange="NMS"
symbol="FPRX"
volume="482528"
weeks_range_52="31.19 - 60.98"
